All News

Jeremiah J. Duby, PharmD, BCPS, BCCCP, describes supporting pharmacy residents at the University of California (UC), Davis, in his role as a research advisor.

Children who had chronic, early-onset, nonanterior uveitis were at an increased risk of developing other complications surrounding the eye.

Adherence can lead to better outcomes, higher starts for Medicare Advantage plans, and stronger financial performance.

High discontinuation rates of semaglutide among older adults with diabetes reveal challenges in long-term adherence and highlight the need for improved support strategies.

Proposed Medicaid cuts threaten children's health coverage, exacerbating existing gaps and impacting access to care for vulnerable populations.

The relationship between caffeine and rheumatoid arthritis has been inconsistent across prior studies.

Any potential reduction in access to pre-exposure prophylaxis (PrEP) would increase both cost and the number of diagnoses of HIV.

Leucovorin is under FDA review to expand treatment for children with cerebral folate deficiency, which has been assciated with autism.

Discover groundbreaking discussions at the European Respiratory Society Congress 2025, focusing on severe asthma, e-cigarette debates, and global health equity in respiratory care.

Patient-Centered Oncology Care (PCOC) conference co-chairs Kathy Oubre, MS, and Davey Daniel, MD, explain how the event unites experts to explore evolving oncology care and patient-centered strategies.

Teclistamab shows promising real-world effectiveness and safety in older adults with relapsed/refractory multiple myeloma (R/R MM), matching clinical trial outcomes.

Medicare beneficiaries with near low income experience more affordability issues than beneficiaries with low income due to Medicare savings programs eligibility.

New research reveals that changes in normal-appearing white and gray matter significantly impact MS progression, challenging traditional lesion-focused views.

A new report identified 11 additional high-frequency mutations in small-cell lung cancer.

Four autophagy-related variants in CDKN2A and BCL2 may increase susceptibility to chronic lymphocytic leukemia (CLL).

Oral nicotinamide reduced the risk of new skin cancers—especially squamous cell carcinoma—by up to 54% when started after a first diagnosis.

These patients had a higher spleen-to-liver stiffness ratio than those with alcohol-related liver disease, warranting a closer look at testing.

Funding cuts to childhood cancer research have put the subspecialty in a precarious position during Childhood Cancer Awareness Month.

The ease of acquiring prior authorizations for a new formulary drug plays a part in evaluating oncology drugs that are new to the market.

The Trump administration highlighted a potential autism risk from prenatal acetaminophen use, but studies demonstrate conflicting evidence.

Only a fraction of countries in the world have designated chronic kidney disease as a health priority.

Patients with progressive pulmonary fibrosis had longer survival with antifibrotic therapy, but only if they met a key criteria.

As oncology continues to move more toward precision medicine, tools like EVOFLUx may offer a more personalized roadmap from diagnosis to treatment.

Medicare beneficiaries with near low income struggle most with health care affordability, highlighting gaps in financial assistance programs.

Cemiplimab demonstrated a 56% overall survival rate, making it a potential option for physicians to use for treating non–small cell lung cancer (NSCLC).

Same-sex couples now report higher insurance coverage than different-sex couples, but disparities by income, geography, and marital status remain.

New research highlights caregiver perspectives to improve colorectal cancer screening access for individuals with intellectual and developmental disabilities.

Tirzepatide appears more cost-effective than semaglutide for obesity and knee osteoarthritis, though long-term data and patient-centered outcomes remain key.